[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:menstrual-migraine":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":23,"states":24},"Menstrual migraine",2,1,[8,16],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06641466","A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine",[12],"Phase 3","RECRUITING","2026-08-26T02:19:19.975067Z","2026-05-05T02:43:28.819136Z",{"nct_id":17,"title":18,"phases":19,"status":20,"updated_at":21,"content_modified":22},"NCT06417775","Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:14:13.878583Z","2026-05-05T02:35:31.756810Z",[],[]]